Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.

Wurm, Raphael

Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles. [electronic resource] - Heart (British Cardiac Society) 10 2016 - 1544-51 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study

1468-201X

10.1136/heartjnl-2015-308711 doi


Aged
Austria
Biomarkers--blood
Cardiovascular Diseases--blood
Chi-Square Distribution
Diabetes Mellitus, Type 2--blood
Female
Humans
Hypoglycemic Agents--adverse effects
Male
Metformin--adverse effects
Middle Aged
Natriuretic Peptide, Brain--blood
Peptide Fragments--blood
Proportional Hazards Models
Prospective Studies
Protective Factors
Risk Assessment
Risk Factors
Sulfonylurea Compounds--adverse effects
Time Factors
Treatment Outcome